IP Library Granted Patent US 6,887,696
Granted Patent B2
US 6,887,696 · App. 09/993,059 · Granted May 3, 2005

Production of lysosomal enzymes in plants by transient expression

Assignee: Large Scale Biology Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,887,696
App. No.
09/993,059
Granted
May 3, 2005
Kind
B2
Abstract

The invention relates to α-galactosidase truncated at the carboxy terminus and the production of enzymatically active recombinant human and animal lysosomal enzymes involving construction and expression of recombinant expression constructs comprising coding sequences of human or animal lysosomal enzymes in a plant expression system. The plant expression system provides for post-translational modification and processing to produce a recombinant gene product exhibiting enzymatic activity. The invention is demonstrated by working examples in which transgenic tobacco plants express recombinant expression constructs comprising human glucocerebrosidase nucleotide sequences. The invention is also demonstrated by working examples in which transfected tobacco plants express recombinant viral expression constructs comprising human α galactosidase nucleotide sequences. The recombinant lysosomal enzymes produced in accordance with the invention may be used for a variety of purposes, including but not limited to enzyme replacement therapy for the therapeutic treatment of human and animal lysosomal storage diseases.

Claims (5)

1. An isolated polypeptide comprising the amino acid sequence of SEQ ID NO: 18.

2. The isolated polypeptide according to claim 1 , wherein said polypeptide is glycosylated at least at one amino acid position selected from the group consisting of amino acid positions 108 , 161 , 184 , and 337 of SEQ ID NO: 18.

3. The isolated polypeptide according to claim 1 , wherein said polypeptide is glycosylated at least at one amino acid position selected from the group consisting of amino acid positions 108 , 161 , and 184 of SEQ ID NO:18.

4. The isolated polypeptide according to claim 1 , wherein said polypeptide has a plant glycosylation pattern at amino acid positions 108 , 161 , and 184 of SEQ ID NO:18, wherein an alpha 1,3 fucose is present on the proximal N-acetylglucosamine (GlcNac).

5. The isolated polypeptide according to claim 1 , wherein said polypeptide has a plant glycosylation pattern at amino acid positions 108 , 161 , and 184 of SEQ ID NO:18, wherein a beta 1,2 xylose is present on a beta-linked mannose of the core.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2007
From: LARGE SCALE BIOLOGY CORPORATION
To: KENTUCKY BIOPROCESSING, LLC
Reel/Frame 020254/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2005
From: POGUE, GREGORY P.
To: LARGE SCALE BIOLOGY CORPORATION
Reel/Frame 016649/0048 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2002
From: TURPEN, THOMAS H.; GARGER, STEPHEN J.; KUMAGAI, MONTO H.
To: LARGE SCALE BIOLOGY CORPORATION
Reel/Frame 012779/0464 →
Continuity (2)
Continuation In Part 0962612700 · Jul 26, 2000
Related Publication 20020088024A1 · Jul 4, 2002